Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Chorea Gravidarum

  • Author: Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS; Chief Editor: Selim R Benbadis, MD  more...
 
Updated: Oct 13, 2014
 

Background

Chorea gravidarum (CG) is the term given to chorea occurring during pregnancy. This is not an etiologically or pathologically distinct morbid entity but a generic term for chorea of any cause starting during pregnancy. Chorea is an involuntary abnormal movement, characterized by abrupt, brief, nonrhythmic, nonrepetitive movement of any limb, often associated with nonpatterned facial grimaces.[1, 2, 3]

Chorea gravidarum is regarded as a syndrome rather than a specific disease entity.

Incidence

Most of the more common and serious movement disorders rarely occur during reproductive years. Hence clinicians are not very familiar with chorea gravidarum. Willson and Preece (1932) found that the overall incidence of chorea gravidarum was approximately 1 case per 300 deliveries.[4] According to them, the first description of chorea with onset during pregnancy was made by Horstius in 1661. The condition is much more rare now. Zegart and Schwartz (1968) found that one patient had been encountered in the course of 139,000 deliveries in 3 major Philadelphia hospitals.[5] The decline is probably the result of a decline in rheumatic fever (RF), which was a major cause of chorea gravidarum before the use of antibiotics for streptococcal pharyngitis.

In recent times, most cases of chorea appearing during pregnancy are caused by other diseases (eg, systemic lupus erythematosus [SLE], Huntington disease). In general, about half the cases are idiopathic, with rheumatic fever and antiphospholipid syndrome (APLS) underlying most of the remainder.[6]

Patient profile

Most patients with chorea gravidarum are young; the average age is 22 years.[4] Almost all reported patients have been Caucasians, although this may be due to a bias in the older literature, in which the vast majority of reported cases are among European patients. Of initial attacks, 80% occur during first pregnancies, and one half start during the first trimester.[4] One third begin in the second trimester. Of afflicted women, 60% previously had chorea. Recurrences may occur in subsequent pregnancies, particularly if antiphospholipid syndrome is the cause. A family history of transient chorea is not unusual.

Next

Pathophysiology

Several pathogenetic mechanisms for chorea gravidarum have been offered, but none have been proven. Willson and Preece noted that nearly 70% of their patients gave a previous history of either rheumatic fever or chorea.[4] Of patients who present with chorea and no apparent carditis, 20% may develop rheumatic heart disease after 20 years. Interestingly, 50% of patients with oral contraceptive-induced chorea have a past history of chorea, which in 41% of cases is of rheumatic origin. The suggestion is that estrogens and progestational hormones may sensitize dopamine receptors (presumably at a striatal level) and induce chorea in individuals who are vulnerable to this complication by virtue of preexisting pathology in the basal ganglion.

Pathologic changes found at autopsy in chorea gravidarum include perivascular degenerative changes in the caudate nucleus.

Pathology of rheumatic brain disease is of a nonspecific arteritis with endothelial swelling, perivascular lymphocytic infiltration, and petechial hemorrhages. Aschoff bodies are not present in the brain.[7, 8] These changes are evident to some extent throughout the cerebrum but are most prominent in the corpus striatum. Severe neuronal loss occurs in the caudate nucleus and putamen. The same pathologic changes have been reported for chorea gravidarum, but all those patients also had cardiac disease.[4] Brain tissue from patients with acute rheumatic fever with or without chorea has not been studied for the presence of antistreptococcal antibodies. Presumably, as the inflammation resolves, the chorea disappears and degenerative changes are left in small arterioles.

Several lines of evidence suggest that heightened dopamine activity occurs either by denervation hypersensitivity or by aberrant sprouting of dopamine terminals on the remaining striatal neurons. A possible relationship between chorea gravidarum and moyamoya disease has been reported in a 16-year-old pregnant patient.[9] The choreic movements may be caused by ischemia or enhanced dopaminergic sensitivity mediated by increased female hormones during pregnancy.

Koide et al reported that from 1994-2004, 8 patients were diagnosed with clinically definite opsoclonus-myoclonus syndrome (a movement disorder) at Tokyo Metropolitan Neurological Hospital. This rare disorder occurred during pregnancy in 25% of their cases and they raised the possibility of a susceptibility factor in pregnancy. The relationship between opsoclonus-myoclonus syndrome and pregnancy, like chorea gravidarum, remains unclear.[10]

Previous
 
 
Contributor Information and Disclosures
Author

Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS Professor Emeritus of Neurology and Psychiatry, Clinical Professor of Medicine, Clinical Professor of Family Medicine, Clinical Professor of Neurosurgery, State University of New York Upstate Medical University; Neuroscience Director, Department of Neurology, Crouse Irving Memorial Hospital

Tarakad S Ramachandran, MBBS, MBA, MPH, FAAN, FACP, FAHA, FRCP, FRCPC, FRS, LRCP, MRCP, MRCS is a member of the following medical societies: American College of International Physicians, American Heart Association, American Stroke Association, American Academy of Neurology, American Academy of Pain Medicine, American College of Forensic Examiners Institute, National Association of Managed Care Physicians, American College of Physicians, Royal College of Physicians, Royal College of Physicians and Surgeons of Canada, Royal College of Surgeons of England, Royal Society of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Nestor Galvez-Jimenez, MD, MSc, MHA The Pauline M Braathen Endowed Chair in Neurology, Chairman, Department of Neurology, Program Director, Movement Disorders, Department of Neurology, Division of Medicine, Cleveland Clinic Florida

Nestor Galvez-Jimenez, MD, MSc, MHA is a member of the following medical societies: American Academy of Neurology, American College of Physicians, International Parkinson and Movement Disorder Society

Disclosure: Nothing to disclose.

Chief Editor

Selim R Benbadis, MD Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, Tampa General Hospital, University of South Florida College of Medicine

Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cyberonics; Eisai; Lundbeck; Sunovion; UCB; Upsher-Smith<br/>Serve(d) as a speaker or a member of a speakers bureau for: Cyberonics; Eisai; Glaxo Smith Kline; Lundbeck; Sunovion; UCB<br/>Received research grant from: Cyberonics; Lundbeck; Sepracor; Sunovion; UCB; Upsher-Smith.

Additional Contributors

Stephen T Gancher, MD Adjunct Associate Professor, Department of Neurology, Oregon Health Sciences University

Stephen T Gancher, MD is a member of the following medical societies: American Academy of Neurology, American Neurological Association, International Parkinson and Movement Disorder Society

Disclosure: Nothing to disclose.

References
  1. Kranick SM, Mowry EM, Colcher A, Horn S, Golbe LI. Movement disorders and pregnancy: a review of the literature. Mov Disord. 2010 Apr 30. 25(6):665-71. [Medline].

  2. Pandey S. Chorea. J Assoc Physicians India. 2013 Jul. 61(7):471-4, 483. [Medline].

  3. Miyasaki JM, Aldakheel A. Movement disorders in pregnancy. Continuum (Minneap Minn). 2014 Feb. 20(1 Neurology of Pregnancy):148-61. [Medline].

  4. Willson P, Preece AA. Chorea gravidarum. Arch Intern Med. 1932. 49:471-533, 671-697.

  5. Zegart KN, Schwarz RH. Chorea gravidarum. Obstet Gynecol. 1968 Jul. 32(1):24-7. [Medline].

  6. Dike GL. Chorea gravidarum: a case report and review. Md Med J. 1997 Sep. 46(8):436-9. [Medline].

  7. Greenfield JG, Wolfsohn JM. The pathology of Sydenham's chorea. Lancet. 1922. 2:603-606.

  8. Winkelman NW, Eckel JL. The brain in acute rheumatic fever. Arch Neurol Psych. 1932. 28:844-870.

  9. Unno S, Iijima M, Osawa M, et al. [A case of chorea gravidarum with moyamoya disease]. Rinsho Shinkeigaku. 2000 Apr. 40(4):378-82. [Medline].

  10. Koide R, Sakamoto M, Tanaka K, Hayashi H. Opsoclonus-myoclonus syndrome during pregnancy. J Neuroophthalmol. 2004 Sep. 24(3):273. [Medline].

  11. Black M. Two cases of chorea in pregnancy. Glasgow Med J. 1900. 441-444.

  12. Matthews AA. Chorea complicating pregnancy. Northwest Med. 1911. 15:372.

  13. Taranta A, Stollerman GH. The relationship of Sydenham's chorea to infection with group A streptococci. Am J Med. 1956 Feb. 20(2):170-5. [Medline].

  14. TARANTA A. Relation of isolated recurrences of Sydenham's chorea to preceding streptococcal infections. N Engl J Med. 1959 Jun 11. 260(24):1204-10. [Medline].

  15. Jonas S, Spagnuolo M, Kloth HH. Chorea gravidarum and streptococcal infection. Obstet Gynecol. 1972 Jan. 39(1):77-9. [Medline].

  16. ARON AM, FREEMAN JM, CARTER S. THE NATURAL HISTORY OF SYDENHAM'S CHOREA. REVIEW OF THE LITERATURE AND LONG-TERM EVALUATION WITH EMPHASIS ON CARDIAC SEQUELAE. Am J Med. 1965 Jan. 38:83-95. [Medline].

  17. Warren HA, Chornyak J. Cerebral manifestations of acute rheumatic fever. Arch Int Med. 1947. 79:589-601.

  18. CHUN RW, SMITH NJ, FORSTER FM. Papilledema in Sydenham's chorea. Am J Dis Child. 1961 May. 101:641-4. [Medline].

  19. Usher SJ, Jasper HH. The etiology of Sydenham's chorea:electroencephalographic studies. CMAJ. 1941. 44:365-371.

  20. Buchanan DN, Walker AE, Case TJ. The pathogenesis of chorea. J Pediatr. 1942. 20:555-575.

  21. Miranda M, Cardoso F, Giovannoni G, Church A. Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies. J Neurol Neurosurg Psychiatry. 2004 Feb. 75(2):327-8. [Medline].

  22. Dale RC. Autoimmunity and the basal ganglia: new insights into old diseases. QJM. 2003 Mar. 96(3):183-91. [Medline].

  23. Archelos JJ, Hartung HP. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 2000 Jul. 23(7):317-27. [Medline].

  24. Wild EJ, Tabrizi SJ. The differential diagnosis of chorea. Pract Neurol. 2007 Nov. 7(6):360-73. [Medline].

  25. Brett WR. Some paediatric eponyms: IV. Sydenham's Chorea. Br J Child Dis. 1932. 29:283.

  26. Marques-Dias MJ, Mercadante MT, Tucker D, Lombroso P. Sydenham's chorea. Psychiatr Clin North Am. 1997 Dec. 20(4):809-20. [Medline].

  27. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies in movement disorders. Pediatrics. 1993 Jul. 92(1):39-43. [Medline].

  28. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998 Feb. 155(2):264-71. [Medline].

  29. Dale RC, Church AJ, Surtees RA, et al. Post-streptococcal autoimmune neuropsychiatric disease presenting as paroxysmal dystonic choreoathetosis. Mov Disord. 2002 Jul. 17(4):817-20. [Medline].

  30. Alvarenga PG, Hounie AG, Mercadante MT, Diniz JB, Salem M, Spina G, et al. Obsessive-compulsive symptoms in heart disease patients with and without history of rheumatic fever. J Neuropsychiatry Clin Neurosci. 2006 Summer. 18(3):405-8. [Medline].

  31. Korn-Lubetzki I, Brand A, Steiner I. Recurrence of Sydenham chorea: implications for pathogenesis. Arch Neurol. 2004 Aug. 61(8):1261-4. [Medline].

  32. Rote NS, Dostal-Johnson D, Branch DW. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin. Am J Obstet Gynecol. 1990 Aug. 163(2):575-84. [Medline].

  33. Triplet DA. New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies. Haemostasis. 1994 May-Jun. 24(3):155-64. [Medline].

  34. Ramsey-Goldman R, Kutzer JE, Kuller LH, et al. Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol. 1992 Oct-Dec. 28(3-4):195-8. [Medline].

  35. Kilpatrick DC, Maclean C, Liston WA, Johnstone FD. Anti-phospholipid antibody syndrome and pre-eclampsia. Lancet. 1989 Oct 21. 2(8669):987-8. [Medline].

  36. Roubey RA. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood. 1994 Nov 1. 84(9):2854-67. [Medline].

  37. Qasim A. An unusual case of chorea gravidarum. Postgrad Med J. 2000 Jun. 76(896):374, 378-9. [Medline].

  38. Asherson RA, Cervera R, Merrill JT, Erkan D. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost. 2008 Apr. 34(3):256-66. [Medline].

  39. Kim, Ok; Kim, A; Seo, M W; Kweon, J Y; Ahn, H Y; Park, et al. Chorea gravidarum associated with Moyamoya disease. J Perinatal Med. 2007. 35(Suppl II):S187.

  40. Husby G, van de Rijn I, Zabriskie JB, et al. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J Exp Med. 1976 Oct 1. 144(4):1094-110. [Medline].

  41. Ichikawa K, Kim RC, Givelber H, Collins GH. Chorea gravidarum. Report of a fatal case with neuropathological observations. Arch Neurol. 1980 Jul. 37(7):429-32. [Medline].

  42. Axley J. Rheumatic chorea controlled with haloperidol. J Pediatr. 1972 Dec. 81(6):1216-7. [Medline].

  43. Shenker DM, Grossman HJ, Klawans HL. Treatment of Sydenham's chorea with haloperidol. Dev Med Child Neurol. 1973 Feb. 15(1):19-24. [Medline].

  44. Patterson JF. Treatment of chorea gravidarum with haloperidol. South Med J. 1979 Sep. 72(9):1220-1. [Medline].

  45. Donaldson JO. Control of chorea gravidarum with haloperidol. Obstet Gynecol. 1982 Mar. 59(3):381-2. [Medline].

  46. Magnier P. [Apropos of vomiting in pregnancy: therapeutic study of R 1625]. Gynecol Prat. 1964. 15(1):17-23. [Medline].

  47. Van Waes A, Van de Velde E. Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Pharmacol. 1969. 9:224.

  48. Shannon KM, Fenichel GM. Pimozide treatment of Sydenham's chorea. Neurology. 1990 Jan. 40(1):186. [Medline].

  49. Pallares AJ, Hurtado L. (Translated title) Carbamazepine in paroxysmal choreoathetosis in Sydenham's chorea. An Esp Pediatr (Anales espanoles pediatrica). 1989. 30 (1):41-44.

  50. Pulsinelli WA, Hamill RW. Chorea complicating oral contraceptive therapy. Case report and review of the literature. Am J Med. 1978 Sep. 65(3):557-9. [Medline].

  51. Nausieda PA, Koller WC, Weiner WJ, Klawans HL. Chorea induced by oral contraceptives. Neurology. 1979 Dec. 29(12):1605-9. [Medline].

  52. Beresford OD, Graham AM. Chorea gravidarum. J Obstet Gynaecol Br Emp. 1950 Aug. 57(4):616-25. [Medline].

  53. Fleischman MJ. A case report of chorea gravidarum complicating five pregnancies. Am J Obstet Gynecol. 1953 Dec. 66(6):1328-30. [Medline].

  54. Ghanem Q. Recurrent chorea gravidarum in four pregnancies. Can J Neurol Sci. 1985 May. 12(2):136-8. [Medline].

  55. BEAN WB, COGSWELL R. Vascular changes of the skin in pregnancy; vascular spiders and palmar erythema. Surg Gynecol Obstet. 1949 Jun. 88(6):739-52. [Medline].

  56. Cardoso F, Eduardo C, Silva AP, Mota CC. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997 Sep. 12(5):701-3. [Medline].

  57. Donaldson JO. Movement disorders. Neurology of Pregnancy. Major Problems In Neurology. Philadelphia: WB Saunders Co; 1978. Vol 7: 87-97.

  58. Forrest AD, Hales IB. Severe chorea gravidarum treated with corticotrophin. Lancet. 1956 Oct 27. 271(6948):874-5. [Medline].

  59. Markham CH, Ansel RD. Drugs and motor behaviour. Jarvik ME, ed. Psychopharmacology in the Practice of Medicine. NY: Appleton Century Crofts; 1977. 127-139.

  60. Wall C, Andrews HR. On chorea in pregnancy. J Obstet Gynaecol Br. 1903. 3:540-547.

  61. Winkelbauer RG, Kimsey LR. Chorea gravidarum treated with chlorpromazine; case report. Am J Obstet Gynecol. 1956 Jun. 71(6):1353-4. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.